{
    "code": "01057188",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01057188",
    "time": "2022-02-04 03:34:43",
    "許可證字號": "衛署藥製字第057188號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/04\/18",
    "發證\/登錄日期": "101\/04\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00105718807",
    "中文品名": "&quot;信東&quot;痰立消持續藥效膠囊75毫克",
    "英文品名": "Tanlixol S.R. Capsules 75mg",
    "適應症": "袪痰。",
    "劑型": "133持續性藥效膠囊劑",
    "包裝": "2-1000粒塑膠瓶裝 2-1000粒鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "AMBROXOL HYDROCHLORIDE",
    "限制項目": "01國　產 1R不得製造 24監視期滿學名藥 61完成BE試驗",
    "申請商名稱": "0908703200  信東生技股份有限公司",
    "申請商地址": "桃園市桃園區介壽路２２號",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4800001810",
            "成分名稱": "AMBROXOL HYDROCHLORIDE",
            "含量描述": "",
            "含量": "75.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Tanlixol S.R. Capsules 75mg-仿單-106-06-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057188&Seq=002&Type=9"
        },
        {
            "title": "010571880001___20120528.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057188&Seq=001&Type=9"
        },
        {
            "title": "010571880004___20120528.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057188&Seq=003&Type=8"
        }
    ]
}